Author:
Darroudi Susan,Abolbashari Samaneh,Ahangari Najmeh,Tayefi Maryam,Khashyarmanesh Zahra,Zamani Parvin,Haghighi Hamideh Moalemzadeh,Mohammadpour Amir Hooshang,Tavalaei Shima,Esmaily Habibollah,Ferns Gordon A.,Meshkat Zahra,Tayefi Batool,Ghayour-Mobarhan Majid
Funder
Mashhad University of Medical Sciences
Publisher
Springer Science and Business Media LLC
Subject
Biochemistry (medical),Inorganic Chemistry,Clinical Biochemistry,General Medicine,Biochemistry,Endocrinology, Diabetes and Metabolism
Reference48 articles.
1. Galvão-Castro B, Loures L, Rodriques L, Sereno A, Ferreira O Jr, Franco L et al (1997) Distribution of human T-lymphotropic virus type I among blood donors: a nationwide Brazilian study. Transfusion 37(2):242–243
2. Carneiro-Proietti ABF, Catalan-Soares B, Proietti FA (2002) Human T cell lymphotropic viruses (HTLV-I/II) in South America: should it be a public health concern? J Biomed Sci 9(6):587–595
3. Hlela C, Shepperd S, Khumalo NP, Taylor GP (2009) The prevalence of human T-cell lymphotropic virus type 1 in the general population is unknown. AIDS Rev 11(4):205–214
4. Bhigjee A, Harvey M, Windsor I, Bill P (1989) Blood transfusion and HTLV-I-associated myelopathy. South African medical journal= Suid-Afrikaanse tydskrif vir geneeskunde 76(12):700
5. Gessain A, Vernant J, Maurs L, Barin F, Gout O, Calender A (1985) Antibodies to human T-lymphotropic virus type-I in patients with tropical spastic paraparesis. Lancet 326(8452):407–410